🔎 Trials Near Me

Hjem › Overvægt › Illinois › Chicago

Overvægt kliniske forsøg i Chicago, IL

41 studier for Overvægt søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 2
  • Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07752979

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

RekruttererFase 2
  • Charter Research LLC - Chicago, Chicago
  • Flourish Research - Chicago, Chicago
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

RekruttererFase 3
  • Great Lakes Clinical Trials, Chicago
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

RekruttererFase 3
  • Chicago Research Center, Inc, Chicago
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

RekruttererFase 3
  • Cedar Crosse Research Center, Chicago
  • Northwestern University, Chicago
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekruttererFase 3
  • Rush University Medical Center, Chicago
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RekruttererFase 3
  • Ann and Robert Lurie Children's Hospital of Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RekruttererFase 3
  • Rush University Medical Center, Chicago
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RekruttererFase 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

RekruttererFase 3
  • Research Site, Chicago
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • Eagle Clinical Research, Chicago
  • University of Chicago, Chicago
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

RekruttererFase 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Alder 18 til 75 · Alle køn · Opdateret 22. sep. 2026 · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RekruttererFase 3
  • Flourish Research - Great Lakes Clinical Trials, Chicago
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684235

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

RekruttererFase 3
  • Kailera Clinical Site, Chicago
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07284979

BRIDGE & Friends Trial

RekruttererFrivillige med god helbredstilstand velkomne
  • University of Illinois Chicago, Chicago
Alder 50 til 79 · Alle køn · Opdateret 1. sep. 2026 · NCT07798557

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

RekruttererFrivillige med god helbredstilstand velkomne
  • Illinois Institute of Technology, Chicago
Alder 21 til 74 · Alle køn · Opdateret 27. aug. 2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

RekruttererFase 3
  • Research Site, Chicago
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

RekruttererFase 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Alder 7 til 25 · Alle køn · Opdateret 19. aug. 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

RekruttererFase 3
  • Chicago Clinical Research Institute INC, Chicago
  • Univer Of Illinois at Chicago, Chicago
  • Eagle Clinical Research, Chicago
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07567001

Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older

Rekrutterer
  • Department of Medicine, Vitoux Program on Aging and Prevention, Chicago
Alder 50 til 74 · Alle køn · Opdateret 18. aug. 2026 · NCT06636058

Role of Adiposomes in Endothelial Dysfunction

Rekrutterer
  • University of Illinois at Chicago, Chicago
Alder 18 til 50 · Alle køn · Opdateret 17. aug. 2026 · NCT05199454

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

RekruttererFase 3
  • ACCOMPLISH-1 Research Site, Chicago
Alder 18 til 79 · Alle køn · Opdateret 10. aug. 2026 · NCT07654361

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Rekrutterer
  • Jesse Brown VA Medical Center, Chicago
Alder 18 og opefter · Alle køn · Opdateret 22. jul. 2026 · NCT06390345

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

RekruttererFase 2
  • Mile Square Health Center Chicago, Chicago
  • Mile Square Health Center - Auburn Gresham, Chicago
  • Mile Square Health Center - Englewood, Chicago
  • og 1 flere
Alle aldre · Alle køn · Opdateret 10. jul. 2026 · NCT07332741

PRImary Care Strategies for Weight Management (PRISM) Study

Rekrutterer
  • Rush University Medical Center, Chicago
Alder 18 og opefter · Alle køn · Opdateret 9. jul. 2026 · NCT07288294

Better Lifestyle Counseling for African American Women During Pregnancy

Rekrutterer
  • University of Illinois at Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Alder 18 til 40 · Kvinder · Opdateret 9. jul. 2026 · NCT05234125

Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients

Rekrutterer
  • Prentice Women's Hospital, Chicago
Alder 18 og opefter · Kvinder · Opdateret 26. maj 2026 · NCT06466161

Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors

Rekrutterer
  • Northwestern University-Feinberg School of Medicine, Chicago
Alder 18 og opefter · Alle køn · Opdateret 8. maj 2026 · NCT05687604

EAT: A Reliable Eating Assessment Technology for Free-living Individuals

RekruttererFrivillige med god helbredstilstand velkomne
  • Northwestern University, Chicago
Alder 18 og opefter · Alle køn · Opdateret 7. maj 2026 · NCT06118528

RemI for Post-Bariatric Surgery Weight Regain

RekruttererFrivillige med god helbredstilstand velkomne
  • Rush University, Chicago
Alder 18 til 70 · Alle køn · Opdateret 3. apr. 2026 · NCT06292936

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

RekruttererObservationsstudie
  • Northwestern Memorial Hospital, Chicago
Alder 18 til 70 · Alle køn · Opdateret 17. mar. 2026 · NCT07207148

Predictors of Behavioral Obesity Treatment Outcomes

RekruttererFrivillige med god helbredstilstand velkomne
  • Rush University Medical Center, Chicago
Alder 18 og opefter · Alle køn · Opdateret 11. mar. 2026 · NCT05326477

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
  • Ann and Robert H. Lurie Children's Hospital of Chicago (Part C and Part D), Chicago
Alder 12 til 65 · Alle køn · Opdateret 22. dec. 2025 · NCT06239116

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

RekruttererFase 3
  • University of Chicago, Chicago
Alder 18 til 75 · Alle køn · Opdateret 14. nov. 2025 · NCT06499857

Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors

Rekrutterer
  • University of Illinois Chicago, Chicago
Alder 18 til 99 · Kvinder · Opdateret 10. nov. 2025 · NCT06504914

DNA Methylation and Vascular Function

RekruttererFrivillige med god helbredstilstand velkomne
  • University of Illinois at Chicago, Chicago
Alder 18 til 50 · Alle køn · Opdateret 15. sep. 2025 · NCT03527420

Overvægt forsøg i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.